Home

Kuželky Grant Objev bio gen demonstrace výklenek Jiný den

Biogen South Africa - A Premium Wellness Brand
Biogen South Africa - A Premium Wellness Brand

Biogen | Zone Chemicals
Biogen | Zone Chemicals

Bio-Gen – Private label
Bio-Gen – Private label

Biogen grapples with 'reckoning' over controversial Alzheimer's drug,  reporters find | WBUR News
Biogen grapples with 'reckoning' over controversial Alzheimer's drug, reporters find | WBUR News

Biogen begins cutting jobs following disastrous debut of its Alzheimer's  drug - The Boston Globe
Biogen begins cutting jobs following disastrous debut of its Alzheimer's drug - The Boston Globe

Biogen Blue | Zone Chemicals
Biogen Blue | Zone Chemicals

Testosterone booster Bio-Gen Innovations E1-Max 90 caps PCT post cycle  therapy
Testosterone booster Bio-Gen Innovations E1-Max 90 caps PCT post cycle therapy

Struggling with Alzheimer's launch, Biogen couldn't present 'clear case for  growth' outside of Aduhelm: analyst | Fierce Pharma
Struggling with Alzheimer's launch, Biogen couldn't present 'clear case for growth' outside of Aduhelm: analyst | Fierce Pharma

FDA praise for Biogen's Alzheimer's drug sends it stock soaring by nearly  44 percent - The Boston Globe
FDA praise for Biogen's Alzheimer's drug sends it stock soaring by nearly 44 percent - The Boston Globe

Biogen Offices - Tokyo | Office Snapshots
Biogen Offices - Tokyo | Office Snapshots

Home | Biogen
Home | Biogen

Biogen: Strong Prospects With A Low Valuation (NASDAQ:BIIB) | Seeking Alpha
Biogen: Strong Prospects With A Low Valuation (NASDAQ:BIIB) | Seeking Alpha

BIO-GEN Foam for Drains - Mega-Lab
BIO-GEN Foam for Drains - Mega-Lab

Aducanumab: will Biogen's Aduhelm recover from its rocky start? -  Pharmaceutical Technology
Aducanumab: will Biogen's Aduhelm recover from its rocky start? - Pharmaceutical Technology

BIO-GEN
BIO-GEN

Biogen Biologics Manufacturing Facility, Solothurn, Switzerland
Biogen Biologics Manufacturing Facility, Solothurn, Switzerland

FDA Head Calls for Probe Into Alzheimer's Drug Review | Chicago News | WTTW
FDA Head Calls for Probe Into Alzheimer's Drug Review | Chicago News | WTTW

FDA panel rejects Biogen's new Alzheimer's drug
FDA panel rejects Biogen's new Alzheimer's drug

Bio-gen Extracts: Beta Caro-gen™, Lute-gen™, Zea-gen™ and Ultra Carogen.
Bio-gen Extracts: Beta Caro-gen™, Lute-gen™, Zea-gen™ and Ultra Carogen.

Biogen Collagen 60 + 30 Combo | Dis-Chem
Biogen Collagen 60 + 30 Combo | Dis-Chem

Rotary homogenizer - Bio-Gen PRO200 - PRO Scientific Inc. - sample  preparation / tissue / hand-held
Rotary homogenizer - Bio-Gen PRO200 - PRO Scientific Inc. - sample preparation / tissue / hand-held

BIO-GEN GSX-R (CARDARINE/SR9) LIQUID | mysite
BIO-GEN GSX-R (CARDARINE/SR9) LIQUID | mysite

Biogen buys Remedy's phase 3 stroke drug for $120M | Fierce Biotech
Biogen buys Remedy's phase 3 stroke drug for $120M | Fierce Biotech

Biogen's Mass. headcount falls by 300 in 10 months - Boston Business Journal
Biogen's Mass. headcount falls by 300 in 10 months - Boston Business Journal

BIO-GEN
BIO-GEN

Biogen makes another Alzheimer's bet, paying Pfizer $75M for early-phase  drug | Fierce Biotech
Biogen makes another Alzheimer's bet, paying Pfizer $75M for early-phase drug | Fierce Biotech